161 related articles for article (PubMed ID: 27294151)
1. Nanoparticle Delivered Human Biliverdin Reductase-Based Peptide Increases Glucose Uptake by Activating IRK/Akt/GSK3 Axis: The Peptide Is Effective in the Cell and Wild-Type and Diabetic Ob/Ob Mice.
Gibbs PE; Miralem T; Lerner-Marmarosh N; Maines MD
J Diabetes Res; 2016; 2016():4712053. PubMed ID: 27294151
[TBL] [Abstract][Full Text] [Related]
2. Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor.
Gibbs PE; Lerner-Marmarosh N; Poulin A; Farah E; Maines MD
FASEB J; 2014 Jun; 28(6):2478-91. PubMed ID: 24568842
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin improves response to glucose tolerance test in control and diabetic rats.
López-Soldado I; Niisuke K; Veiga C; Adrover A; Manzano A; Martínez-Redondo V; Camps M; Bartrons R; Zorzano A; Gumà A
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E440-51. PubMed ID: 26714846
[TBL] [Abstract][Full Text] [Related]
5. A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome.
Kanter JE; Kramer F; Barnhart S; Duggan JM; Shimizu-Albergine M; Kothari V; Chait A; Bouman SD; Hamerman JA; Hansen BF; Olsen GS; Bornfeldt KE
Diabetes; 2018 May; 67(5):946-959. PubMed ID: 29483182
[TBL] [Abstract][Full Text] [Related]
6. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
[TBL] [Abstract][Full Text] [Related]
7. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
8. Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice.
Dong F; Yang X; Sreejayan N; Ren J
Obesity (Silver Spring); 2007 Nov; 15(11):2699-711. PubMed ID: 18070761
[TBL] [Abstract][Full Text] [Related]
9. Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance.
Sylow L; Kleinert M; Pehmøller C; Prats C; Chiu TT; Klip A; Richter EA; Jensen TE
Cell Signal; 2014 Feb; 26(2):323-31. PubMed ID: 24216610
[TBL] [Abstract][Full Text] [Related]
10. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
[TBL] [Abstract][Full Text] [Related]
12. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Endocrinology; 2012 Jul; 153(7):2985-96. PubMed ID: 22581458
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 14 increases insulin sensitivity through activation of PI3K/Akt signal pathway.
Yang M; Ren Y; Lin Z; Tang C; Jia Y; Lai Y; Zhou T; Wu S; Liu H; Yang G; Li L
Cell Signal; 2015 Nov; 27(11):2201-8. PubMed ID: 26226221
[TBL] [Abstract][Full Text] [Related]
15. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
[TBL] [Abstract][Full Text] [Related]
16. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway.
Lu J; Zeng Y; Hou W; Zhang S; Li L; Luo X; Xi W; Chen Z; Xiang M
J Nutr Biochem; 2012 Nov; 23(11):1449-57. PubMed ID: 22278080
[TBL] [Abstract][Full Text] [Related]
17. A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects.
Zhao SJ; Wang DH; Li YW; Han L; Xiao X; Ma M; Wan DC; Hong A; Ma Y
Int J Nanomedicine; 2017; 12():2143-2160. PubMed ID: 28356733
[TBL] [Abstract][Full Text] [Related]
18. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
[TBL] [Abstract][Full Text] [Related]
19. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
20. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
